M. Upcott

Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies

E. Tallantyre, M. Wardle, N. Robertson, 2022, Multiple Sclerosis and Related Disorders.

Toward a Disease-Modifying Therapy of Alpha-Synucleinopathies: New Molecules and New Approaches Came into the Limelight

V. Buchman, K. Chaprov, M. Upcott, 2021, Molecules.

COVID-19 vaccine response in people with multiple sclerosis.

K. Schmierer, Angray S. Kang, N. Evangelou, 2021, Annals of neurology.

Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic

Mohammed I. Alghamdi, Kevin C. Chu, E. R. Lloyd, 2021, The British journal of surgery.

Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination

K. Schmierer, Angray S. Kang, N. Evangelou, 2023, Multiple sclerosis.